Saluda Medical, Inc. (ASX:SLD)

Saluda Medical Statistics

Total Valuation

Saluda Medical has a market cap or net worth of AUD 204.14 million. The enterprise value is 89.69 million.

Market Cap	204.14M
Enterprise Value	89.69M

Important Dates

The last earnings date was Thursday, February 26, 2026.

Earnings Date	Feb 26, 2026
Ex-Dividend Date	n/a

Share Statistics

Saluda Medical has 252.02 million shares outstanding. The number of shares has increased by 1,086.55% in one year.

Current Share Class	n/a
Shares Outstanding	252.02M
Shares Change (YoY)	+1,086.55%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	2.30%
Owned by Institutions (%)	29.02%
Float	5.67M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.79
PB Ratio	1.17
P/TBV Ratio	1.17
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.24
EV / Sales	0.79
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.49

Financial Position

The company has a current ratio of 6.41, with a Debt / Equity ratio of 0.65.

Current Ratio	6.41
Quick Ratio	4.93
Debt / Equity	0.65
Debt / EBITDA	n/a
Debt / FCF	-0.62
Interest Coverage	-4.01

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-67.38%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	857,430
Profits Per Employee	-2.85M
Employee Count	133
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Saluda Medical has paid 1.13 million in taxes.

Income Tax	1.13M
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	1.04
200-Day Moving Average	n/a
Relative Strength Index (RSI)	35.20
Average Volume (20 Days)	107,356

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Saluda Medical had revenue of AUD 114.04 million and -378.77 million in losses. Loss per share was -9.84.

Revenue	114.04M
Gross Profit	54.43M
Operating Income	-194.09M
Pretax Income	-242.65M
Net Income	-378.77M
EBITDA	-191.58M
EBIT	-194.09M
Loss Per Share	-9.84

Balance Sheet

The company has 227.02 million in cash and 112.57 million in debt, with a net cash position of 114.45 million or 0.45 per share.

Cash & Cash Equivalents	227.02M
Total Debt	112.57M
Net Cash	114.45M
Net Cash Per Share	0.45
Equity (Book Value)	174.00M
Book Value Per Share	0.69
Working Capital	273.74M

Cash Flow

In the last 12 months, operating cash flow was -181.16 million and capital expenditures -1.87 million, giving a free cash flow of -183.02 million.

Operating Cash Flow	-181.16M
Capital Expenditures	-1.87M
Depreciation & Amortization	2.42M
Net Borrowing	147.17M
Free Cash Flow	-183.02M
FCF Per Share	-0.73

Margins

Gross margin is 47.73%, with operating and profit margins of -170.20% and -213.77%.

Gross Margin	47.73%
Operating Margin	-170.20%
Pretax Margin	-212.78%
Profit Margin	-213.77%
EBITDA Margin	-168.00%
EBIT Margin	-170.20%
FCF Margin	n/a

Dividends & Yields

Saluda Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1,086.55%
Shareholder Yield	-1,086.55%
Earnings Yield	-185.55%
FCF Yield	-89.66%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Saluda Medical has an Altman Z-Score of -3.24 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.24
Piotroski F-Score	2